rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chase LoPriore

VP, Corp. Dev.

Company insider

Files Form 4 as: VP, Corp. Dev., Hepion Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
2
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
19 Aug 2026
Last trade
19 Aug 2026
Last filed
21 Aug 2026

Companies traded

Where they are an officer
Hepion PharmaceuticalsDirector, Officer · Biotechnology · last 19 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
19 Aug 2026filed 21 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—1,345,500 at $0.00filing
19 Aug 2026filed 21 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—1,345,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Danina FisherDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Vincent S. LoPrioreExecutive Chairman · Executive Chairman at Hepion Pharmaceuticals, filing Form 4 there in the last year
Michael J. PurcellDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Gary S. Stetz IIDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Sireesh AppajosyulaChief Operating Officer · Chief Operating Officer at Hepion Pharmaceuticals, filing Form 4 there in the last year